CN Patent

CN106699743B — 嘧啶类衍生物及其用途

Assigned to Hubei Bio-Pharmaceutical Industrial Technological Institute Inc · Expires 2020-06-12 · 6y expired

What this patent protects

本发明提出了嘧啶类衍生物及其用途。该嘧啶类衍生物为式I所示化合物或式I所示化合物的药学上可接受的盐、水合物、溶剂化物、代谢产物、或前药，其中，R 1 、R 2 、R 3 、R 4 和R 5 如说明书所定义。该化合物能够用作ALK抑制剂，用于制备成抑制间变性淋巴瘤激酶的抗肿瘤治疗药物。

USPTO Abstract

本发明提出了嘧啶类衍生物及其用途。该嘧啶类衍生物为式I所示化合物或式I所示化合物的药学上可接受的盐、水合物、溶剂化物、代谢产物、或前药，其中，R 1 、R 2 、R 3 、R 4 和R 5 如说明书所定义。该化合物能够用作ALK抑制剂，用于制备成抑制间变性淋巴瘤激酶的抗肿瘤治疗药物。

Drugs covered by this patent

Patent Metadata

Patent number
CN106699743B
Jurisdiction
CN
Classification
—
Expires
2020-06-12
Drug substance claim
No
Drug product claim
No
Assignee
Hubei Bio-Pharmaceutical Industrial Technological Institute Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.